InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting ...
Calorie restriction lowers C3, an immune protein tied to aging and inflammation, improving health without requiring weight ...
InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting ...
Izicopan is an investigational next-generation oral C5aR1 inhibitor designed to achieve differentiated pharmacological properties, with the potential for improved efficacy and safety. The marketed ...
One-Year Cohort 1 Data and Initial Cohort 2 Data from RIDGE™-1 Phase 1b/2 Trial of TN-401 for PKP2-Associated ARVC to be Presented at ASGCT ...
Our expert reviews the best stability running shoes for overpronation and flat feet, featuring top-rated models from Brooks, ...
Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...
Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other ...
Nasal vaccines represent a promising shift in how we prevent infectious diseases. By building immunity at the body's first line of defence, they could stop infections before they begin, reduce ...
In a makeshift demonstration kitchen in Concord, California, cooking oil splatters in and around a frying pan, which catches ...
Jenna Bromberg digs into recent moves around marketing co-ops and agency partners and how the chain is working with Google ...
South African municipalities have activated emergency preparedness and response measures as severe weather affecting five provinces has already claimed several lives, the South African Local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results